The Measure of Sickle Cell Stigma: Initial findings from the Improving Patient Outcomes through Respect and Trust study
Links to Files
https://journals.sagepub.com/doi/10.1177/1359105314539530Collections
Metadata
Show full item recordDate
2014-07-04Type of Work
16 pagesText
journal articles postprints
Citation of Original Publication
Bediako, S. M., Lanzkron, S., Diener-West, M., Onojobi, G., Beach, M. C., & Haywood, C., Jr (2016). The Measure of Sickle Cell Stigma: Initial findings from the Improving Patient Outcomes through Respect and Trust study. Journal of health psychology, 21(5), 808–820. https://doi.org/10.1177/1359105314539530Rights
This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.This is not the final published version. Shawn M Bediako, Sophie Lanzkron, Marie Diener-West, Gladys Onojobi, Mary C Beach, and Carlton Haywood, Jr, The Measure of Sickle Cell Stigma: Initial findings from the Improving Patient Outcomes through Respect and Trust study,Journal of Health Psychology (Volume Number 21 and Issue Number 5) pp. 808–820. Copyright ©2020 SAGE Publications. DOI: 10.1177/1359105314539530.
Abstract
Research about the influence of stigma on health outcomes in sickle cell disease is limited. We administered the recently developed Measure of Sickle Cell Stigma to 262 patients in the United States. The Measure of Sickle Cell Stigma yielded very good internal consistency and four interpretable factors. Significant associations among stigma, pain-related healthcare utilization, and perceived disease severity were observed for three of the four stigma factors (F range = 2.78–5.44). The Measure of Sickle Cell Stigma appears to be a useful tool for measuring disease-specific stigma among adults living with sickle cell disease, and further assessment of its clinical utility is warranted.